These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2121801)

  • 1. Unaltered drug metabolizing enzyme systems in type II diabetes mellitus before and during glyburide therapy.
    Juan D; Molitch ME; Johnson MK; Carlson RF; Antal EJ
    J Clin Pharmacol; 1990 Oct; 30(10):943-7. PubMed ID: 2121801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of hepatic microsomal enzyme activity using C-l4-labeled aminopyrine breath test in patients with diabetes mellitus type 2 treated with tolbutamide].
    Kamińska-Galwas B; Sroczyński J
    Pol Arch Med Wewn; 1991 Sep; 86(3):142-8. PubMed ID: 1808599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration.
    Muhoberac BB; Hanew T; Halter S; Schenker S
    Biochem Pharmacol; 1989 Nov; 38(22):4103-13. PubMed ID: 2512932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aminopyrine breath test.
    Perri F; Pastore M; Annese V; Andriulli A
    Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of 13C breath tests for microsomal liver function: aminopyrine revisited.
    Pijls KE; de Vries H; Nikkessen S; Bast A; Wodzig WK; Koek GH
    Liver Int; 2014 Apr; 34(4):487-94. PubMed ID: 24428683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
    Meredith CG; Maldonado AL; Speeg KV
    Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the phenacetin and aminopyrine breath tests: effect of liver disease, inducers and cobaltous chloride.
    Schoeller DA; Kotake AN; Lambert GH; Krager PS; Baker AL
    Hepatology; 1985; 5(2):276-81. PubMed ID: 3920135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
    Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nizatidine, a new histamine H2-receptor antagonist, and hepatic oxidative drug metabolism in the rat: a comparison with structurally related compounds.
    Meredith CG; Speeg KV; Schenker S
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):315-24. PubMed ID: 2858133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test.
    Giannini EG; Malfatti F; Botta F; Polegato S; Testa E; Fumagalli A; Mamone M; Savarino V; Testa R
    Dig Dis Sci; 2005 Jul; 50(7):1207-13. PubMed ID: 16047461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of low-dose oral contraceptives, alcohol, and grapefruit on.
    Van Vlierberghe H; Van Durme F; Verdievel H; Dhont M; de Vos M; Elewaut A
    Dig Dis Sci; 2001 Jan; 46(1):133-9. PubMed ID: 11270777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test.
    Hepner GW; Uhlin SR; Lipton A; Harvey HA; Rohrer V
    JAMA; 1976 Oct; 236(14):1587-90. PubMed ID: 989131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CO2 breath tests as monitors of the cytochrome P450 dependent mixed function monooxygenase system.
    Lambert GH; Kotake AN; Schoeller D
    Prog Clin Biol Res; 1983; 135():119-45. PubMed ID: 6420801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [13C]aminopyrine and [13C]caffeine breath test: influence of gender, cigarette smoking and oral contraceptives intake.
    Caubet MS; Laplante A; Caillé J; Brazier JL
    Isotopes Environ Health Stud; 2002 Jun; 38(2):71-7. PubMed ID: 12219983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glyburide on in vivo insulin-mediated glucose disposal.
    Simonson DC
    Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity.
    Fontana RJ; Turgeon DK; Woolf TF; Knapp MJ; Foster NL; Watkins PB
    Hepatology; 1996 Jun; 23(6):1429-35. PubMed ID: 8675160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dietary protein on theophylline pharmacokinetics and caffeine and aminopyrine breath tests.
    Juan D; Worwag EM; Schoeller DA; Kotake AN; Hughes RL; Frederiksen MC
    Clin Pharmacol Ther; 1986 Aug; 40(2):187-94. PubMed ID: 3731681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of age, gender, and sexual maturation on the caffeine breath test.
    Lambert GH; Schoeller DA; Kotake AN; Flores C; Hay D
    Dev Pharmacol Ther; 1986; 9(6):375-88. PubMed ID: 3102191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.